Claritas Pharmaceuticals, Inc. Share Price
Equities
CLAS.H
CA1806342061
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | -16.67% | -.--% | -.--% |
Sales 2019 | - | Sales 2020 | - | Capitalization | 13.65M 18.66M 1.09B |
---|---|---|---|---|---|
Net income 2019 | -21M -28.71M -1.68B | Net income 2020 | 4M 5.47M 319M | EV / Sales 2019 | - |
Net Debt 2019 | 704K 962K 56.23M | Net Debt 2020 | 920K 1.26M 73.48M | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1 day | -16.67% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 691K | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CLAS.H Stock